Back to results

CompletedPhase 4

Colesevelam for Children With Type 2 Diabetes

NCT01258075

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Tucson, Arizona, United States

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2011-02-24
Enrollment: 236 participants
Sponsor: Daiichi Sankyo
Purpose: treatment

Locations (24)

Tucson, Arizona, United States
Little Rock, Arkansas, United States
Los Angeles, California, United States
Oakland, California, United States
San Diego, California, United States
Aurora, Colorado, United States
Hartford, Connecticut, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Kansas City, Kansas, United States
Baltimore, Maryland, United States
Springfield, Massachusetts, United States
New York, New York, United States
Raleigh, North Carolina, United States
Cincinnati, Ohio, United States
Oklahoma City, Oklahoma, United States
Oklahoma City, Oklahoma, United States
Philadelphia, Pennsylvania, United States
Greenville, South Carolina, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Houston, Texas, United States
San Antonio, Texas, United States

Colesevelam for Children With Type 2 Diabetes — TrialFind